The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND/OBJECTIVES: Immune checkpoint inhibitors are frequently used to treat advanced non-small cell lung cancer (NSCLC). Drug clearance also varies depending on patient-related factors. Therefore, the lung immune prognostic index (LIPI), based on inflammatory markers, may help predict prognosis. Early changes in LIPI may predict treatment response and survival. METHODS: This multicenter study included 707 patients with NSCLC. LIPI was calculated at baseline and one month after treatment initiation. Patients were categorized into two groups: those with stable or improved LIPI scores and those with worsened LIPI scores. Survival outcomes and prognostic significance were analyzed. RESULTS: Median progression free survival was 9 months in patients with stable or improved LIPI and 6 months in those with worsened LIPI (p = 0.005). Median overall survival was 15 months in the stable/improved LIPI group and 9 months in the worsened LIPI group (p = 0.001). CONCLUSION: Changes in LIPI can be assessed using routine laboratory tests as early as the second treatment cycle, allowing early prediction of treatment response. Baseline LIPI values and changes in LIPI can predict prognosis.
Source: Discover Oncology
Authors: Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz, Mevlude Inanc, Metin Ozkan, Emel Mutlu Ozkan, Deniz Can Guven, Mustafa Erman, Latif Karahan, Elif Sahin, Anıl Karakayali, Pervin Can Sanci, Umut Kefeli, Devrim Cabuk, Erdem Kolemen, Mehmet Mutlu Kidi, Sedat Biter, Tolga Koseci, Muslih Urun, Berrak Mermit Ercek, Duygu Bayir, Gözde Agdas, Teoman Sakalar, Nargiz Majidova, Sedat Yildiz, Hacer Demir, Cengiz Akosman, Mustafa Ersoy, Saadettin Kilickap, Erkam Kocaaslan, Ezgi Turkoğlu, Sedat Yildirim, Hayati Arvas, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas
Institutions: Erciyes University, Hacettepe University, Kocaeli Üniversitesi, Cukurova University, Van Yüzüncü Yıl Üniversitesi, Eskişehir Osmangazi University, Afyonkarahisar Sağlık Bilimleri Üniversitesi, Istinye University, Marmara University, Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Dicle University, Gaziantep University, Heidelberg University, University Hospital Heidelberg
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,690
OpenAlex ID: W7130818958